Table 1.
Baseline Characteristics
| Variables | Total (N = 160) |
|---|---|
| Gender, n (%) | |
| Male | 52 (32.5) |
| Female | 108 (67.5) |
| Age (years), median (min-max) | 58 (22–78) |
| NAFLD, n (%) | |
| Yes | 115 (71.9) |
| No | 45 (28.1) |
| SIBO, n (%) | |
| Yes | 55 (34.4) |
| No | 105 (65.6) |
| Obesity, n (%) | |
| Yes | 107 (66.9) |
| No | 53 (33.1) |
| DM, n (%) | |
| Yes | 120 (75) |
| No | 40 (25) |
| Dyslipidemia, n (%) | |
| Yes | 129 (80.6) |
| No | 31 (19.4) |
| Metabolic Syndrome, n (%) | |
| Yes | 122 (76.3) |
| No | 38 (23.8) |
| Central Obesity, n (%) | |
| Yes | 149 (93.1) |
| No | 11 (6.9) |
| Fibrosis Degree, n (%) | |
| F0-F1 | 89 (77.4) |
| F2-F4 | 26 (22.6) |
| Steatosis Degree, n (%) | |
| S0 | 41 (26.4) |
| S1 | 10 (6.4) |
| S2 | 4 (2.5) |
| S3 | 60 (38.7) |
| Significant Steatosis, n (%) | |
| Yes | 71 (61.7) |
| No | 44 (38.3) |
SIBO Small Intestinal Bacterial Overgrowth, NAFLD Non-Alcoholic Fatty Liver Disease, DM Diabetes Mellitus, PR Prevalence Ratio, CI Confidence Interval